FDA Panel Set to Review GRAIL Multi-Cancer Blood Test
The FDA is preparing to review GRAIL’s Galleri multi-cancer blood test, a technology designed to detect signals from many cancers through one blood sample soon.
Galleri
The FDA is preparing to review GRAIL’s Galleri multi-cancer blood test, a technology designed to detect signals from many cancers through one blood sample soon.